Clinomic supported by Deutsche Telekom‘s startup program

Clinomic is now supported by Deutsche Telekom‘s startup program, “Techboost Startup”, supported with up to 100,000 euros credit for OTC and discounts on Telekom products and rates. With extensive use of the cloud, TechBoost startups also receive valuable sales and marketing support – true to the motto: Boost your business! What makes the Telekom TechBoost […]

Read More…

New paper: Artificial intelligence and machine learning in intensive care research and clinical application

Hardly any other development is pre-dicted to have a greater impact on our daily working life than artificial intelli-gence (AI). A popular field of application of artificial intelligence is the so-called “machine learning”, the discipline that deals with the generation of computerised knowledge from experience through self-adaptive algoriths. Especially the high practical relevance, for example, […]

Read More…

New publication: Deep learning on Intensive Care Units to visually track medical consumables

Deep learning on Intensive Care Units

High numbers of consumable medical materials (eg, sterile needles and swabs) are used during the daily routine of intensive care units (ICUs) worldwide. Although medical consumables largely contribute to total ICU hospital expenditure, many hospitals do not track the individual use of materials. Current tracking solutions meeting the specific requirements of the medical environment, like […]

Read More…

Clinomic receives funding by Ministry for Economic Affairs, Innovation, Digitisation and Energy of the State of North Rhine-Westphalia

Clinomic is happy to announce the support of the Ministry of Economic Affairs, Innovation, Digitisation and Energy of the State of North Rhine-Westphalia (Germany) in the “Mittelstand Innovativ” program. The capacity for innovative change and digital transformation has increasingly become the decisive competitive parameter. For many medium-sized companies it is a great challenge to recognize […]

Read More…

This site is registered on wpml.org as a development site. Switch to a production site key to remove this banner.